Form 4 for NVAX NOVAVAX INC
Accepted 2026-03-03 00:00:00 ET · period of report 2026-03-01 · accession 0001104659-26-023070 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-03 | 2026-03-01 | NVAX | O'Hara Elaine | EVP, Chief Strategy Off | M - OptEx | $0.00 | +59.6K | 77.1K | +341% | $0 |
| DM | 2026-03-03 | 2026-03-01 | NVAX | O'Hara Elaine | EVP, Chief Strategy Off | F - Tax | $10.14 | -16.3K | 100.7K | -14% | -$165.7K |
| DM | 2026-03-03 | 2026-03-01 | NVAX | O'Hara Elaine | EVP, Chief Strategy Off | M - OptEx | $0.00 | -59.6K | 40.0K | -60% | $0 |
| DM | 2026-03-03 | 2026-03-02 | NVAX | O'Hara Elaine | EVP, Chief Strategy Off | A - Grant | $5.46 | +295.5K | 177.5K | New | +$1.61M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-01 | M | A | 40,000 | $0.00 | 111,706 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-01 | F | D | 5,375 | $10.14 | 71,706 | D | — | — | (F1) Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. |
| 3 | Common | Common Stock | 2026-03-01 | M | A | 19,600 | $0.00 | 77,081 | D | — | — | |
| 4 | Common | Common Stock | 2026-03-01 | F | D | 10,969 | $10.14 | 100,737 | D | — | — | (F1) Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. |
| 5 | Derivative | Restricted Stock Units | 2026-03-01 | M | D | 19,600 | $0.00 | 0 | D | $0.00 · — to 2033-03-01 | 19,600 Common Stock | (F2) One-third (1/3) of the RSUs subject to this grant under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, (the "Plan") vest on each of the first three (3) anniversaries of March 1, 2023, in each case subject to continued employment through such vesting date. |
| 6 | Derivative | Restricted Stock Units | 2026-03-02 | A | A | 118,000 | $0.00 | 118,000 | D | $0.00 · — to 2036-03-02 | 118,000 Common Stock | (F4) One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of March 2, 2026, in each case subject to continued employment through such vesting date. |
| 7 | Derivative | Restricted Stock Units | 2026-03-01 | M | D | 40,000 | $0.00 | 40,000 | D | $0.00 · — to 2034-03-01 | 40,000 Common Stock | (F3) One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of March 1, 2024, in each case subject to continued employment through such vesting date. |
| 8 | Derivative | 2026 Non-statutory Stock Option NQ | 2026-03-02 | A | A | 177,500 | $9.09 | 177,500 | D | $9.09 · — to 2036-03-02 | 177,500 Common Stock | (F5) One-quarter (1/4) of the shares subject to this option granted under the Plan vest on the first anniversary of March 2, 2026, and the remaining three-quarters (3/4) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date. |